Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes.
Iijima Y, Nakayama M, Miwa T, Yakou F, Tomiyama H, Shikuma J, Ito R, Tanaka A, Manda N, Odawara M.
Iijima Y, et al. Among authors: shikuma j.
Intern Med. 2023;62(5):681-688. doi: 10.2169/internalmedicine.6685-20. Epub 2023 Mar 1.
Intern Med. 2023.
PMID: 36858619
Free PMC article.